rs760867179

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001039591.3(USP9X):​c.5920A>G​(p.Ile1974Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,209,575 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 3 hem., cov: 22)
Exomes 𝑓: 0.000098 ( 0 hom. 36 hem. )

Consequence

USP9X
NM_001039591.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.183
Variant links:
Genes affected
USP9X (HGNC:12632): (ubiquitin specific peptidase 9 X-linked) This gene is a member of the peptidase C19 family and encodes a protein that is similar to ubiquitin-specific proteases. Though this gene is located on the X chromosome, it escapes X-inactivation. Mutations in this gene have been associated with Turner syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in the USP9X gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 24 curated pathogenic missense variants (we use a threshold of 10). The gene has 36 curated benign missense variants. Gene score misZ: 6.4105 (above the threshold of 3.09). GenCC associations: The gene is linked to non-syndromic X-linked intellectual disability, X-linked syndromic intellectual disability, intellectual disability, X-linked 99, syndromic, female-restricted, intellectual disability, X-linked 99, X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability.
BP4
Computational evidence support a benign effect (MetaRNN=0.0063857436).
BP6
Variant X-41216487-A-G is Benign according to our data. Variant chrX-41216487-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 599442.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-41216487-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000539 (6/111327) while in subpopulation SAS AF= 0.000761 (2/2629). AF 95% confidence interval is 0.000135. There are 0 homozygotes in gnomad4. There are 3 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USP9XNM_001039591.3 linkc.5920A>G p.Ile1974Val missense_variant Exon 35 of 45 ENST00000378308.7 NP_001034680.2 Q93008-1Q86X58Q6P468

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USP9XENST00000378308.7 linkc.5920A>G p.Ile1974Val missense_variant Exon 35 of 45 5 NM_001039591.3 ENSP00000367558.2 Q93008-1

Frequencies

GnomAD3 genomes
AF:
0.0000539
AC:
6
AN:
111275
Hom.:
0
Cov.:
22
AF XY:
0.0000898
AC XY:
3
AN XY:
33421
show subpopulations
Gnomad AFR
AF:
0.0000327
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000192
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000759
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00417
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000285
AC:
52
AN:
182163
Hom.:
0
AF XY:
0.000266
AC XY:
18
AN XY:
67681
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00128
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000728
Gnomad SAS exome
AF:
0.000629
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000368
Gnomad OTH exome
AF:
0.000224
GnomAD4 exome
AF:
0.0000983
AC:
108
AN:
1098248
Hom.:
0
Cov.:
32
AF XY:
0.0000990
AC XY:
36
AN XY:
363604
show subpopulations
Gnomad4 AFR exome
AF:
0.0000379
Gnomad4 AMR exome
AF:
0.00131
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000662
Gnomad4 SAS exome
AF:
0.000591
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000131
Gnomad4 OTH exome
AF:
0.000174
GnomAD4 genome
AF:
0.0000539
AC:
6
AN:
111327
Hom.:
0
Cov.:
22
AF XY:
0.0000896
AC XY:
3
AN XY:
33483
show subpopulations
Gnomad4 AFR
AF:
0.0000327
Gnomad4 AMR
AF:
0.000191
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000761
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.000166
ExAC
AF:
0.000322
AC:
39
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

USP9X: BP4, BS2 -

Dec 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 11, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Nov 20, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

BS1, BS2, BP4, BP5; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, is predicted to be tolerated by multiple functional prediction tools, and was found in a case with an alternate molecular basis for disease. -

USP9X-related disorder Benign:1
May 23, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.87
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.11
DANN
Benign
0.42
DEOGEN2
Benign
0.18
.;T
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.77
T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0064
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.0
L;L
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.62
N;N
REVEL
Benign
0.037
Sift
Benign
0.21
T;T
Sift4G
Benign
0.39
T;T
Polyphen
0.0
B;B
Vest4
0.043
MutPred
0.37
Gain of catalytic residue at I1974 (P = 0.0788);Gain of catalytic residue at I1974 (P = 0.0788);
MVP
0.11
MPC
0.77
ClinPred
0.010
T
GERP RS
-3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.086
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760867179; hg19: chrX-41075740; COSMIC: COSV61077112; API